Association of Galanin and Major Depressive Disorder in the Chinese Han Population

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wang, Yong Jun ^a,c   Li, Hui ^b   Yang, Yu Tao ^b   Tie, Chang Le ^c   Li, Feng ^c   Da Xu, Zhi Qingvid ^b   Wang, Chuan Yue ^c  

^a TIANJIN ANDING HOSPITAL   (China)

^b BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; GENOMIC DNA;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DSM-IV; ETHNIC DIFFERENCE; FEMALE; GALANIN GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOLECULAR PATHOLOGY; MORBIDITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GALANIN; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 84878526475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064617     Document Type: Article

References (22)

1. Wray NR, Pergadia ML, Blackwood DH, Penninx BW, Gordon SD, et al. (2012) Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry 17: 36-48.
2. Andrews G, Poulton R, Skoog I, (2005) Lifetime risk of depression: restricted to a minority or waiting for most? Br J Psychiatry 187: 495-496.
3. Blair-West GW, Cantor CH, Mellsop GW, Eyeson-Annan ML, (1999) Lifetime suicide risk in major depression: sex and age determinants. J Affect Disord 55: 171-178.
4. Lohoff FW, (2010) Overview of the genetics of major depressive disorder, Curr Psychiatry Rep. 12: 539-46.
5. Kendler KS, Sheth K, Gardner CO, Prescott CA, (2002) Childhood parental loss and risk for first-onset of major depression and alcohol dependence: the time-decay of risk and sex differences. Psychol Med 32: 1187-1194.
6. Weizman S, Gonda X, Dome P, Faludi G, (2012) Pharmacogenetics of antidepressive drugs: a way towards personalized treatment of major depressive disorder, Neuropsychopharmacol Hung. 14: 87-101.
7. Rhee SH, Waldman ID, (2002) Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol Bull 128: 490-529.
8. Malhi GS, Moore J, McGuffin P, (2000) The genetics of major depressive disorder, Curr Psychiatry Rep. 2: 165-9.
9. Kendler KS, Prescott CA, (1999) A population-based twin study of lifetime major depression in men and women. Arch Gen Psychiatry 56: 39.
10. Murck H, Held K, Ziegenbein M, Künzel H, Holsboer F, et al. (2004) Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29: 1205-1211.
11. Artero S, Touchon J, Dupuy AM, Malafosse A, Ritchie K, (2011) War exposure, 5-HTTLPR genotype and lifetime risk of depression. Br J Psychiatry 199: 43-48.
12. Kiyohara C, Yoshimasu K, (2010) Association between major depressive disorder and a functional polymorphism of the 5-hydroxytryptamine (serotonin) transporter gene: a meta-analysis. Psychiatr Genet 20: 49-58.
13. El Mansari M, Guiard BP, Chernoloz O, Ghanbari R, Katz N, et al. (2010) Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder. CNS Neurosci Ther 16: e1-17.
14. Xu Y, Li F, Huang X, Sun N, Zhang F, et al. (2009) The norepinephrine transporter gene modulates the relationship between urban/rural residency and major depressive disorder in a Chinese population. Psychiatry Res 168: 213-217.
15. Christiansen SH, Olesen MV, Wortwein G, Woldbye DP, (2011) Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice. Behav Brain Res 216: 585-591.
16. Kuteeva E, Hokfelt T, Wardi T, Ogren SO, (2010) Galanin, galanin receptor subtypes and depression-like behaviour. EXS 102: 163-181.
17. Yoshitake T, Reenila I, Ogren SO, Hokfelt T, Kehr J, (2003) Galanin attenuates basal and antidepressant drug-induced increase of extracellular serotonin and noradrenaline levels in the rat hippocampus. Neurosci Lett 339: 239-242.
18. Xu Z-Q D, Zhang X, Pieribone VA, Grillner S, Hökfelt T, (1998) Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87: 79-94.
19. Xu Z-Q D, Zheng K, Hökfelt T, (2005) Electrophysiological studies on galanin effects in brain-progress during the last six years. Neuropeptides 39: 269-752.
20. Unschuld PG, Ising M, Erhardt A, Lucae S, Kohli M, et al. (2008) Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 105: 177-184.
21. Unschuld PG, Ising M, Roeske D, Erhardt A, Specht M, et al. (2010) Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response. Neuropsychopharmacology 35: 1583-1592.
22. Bailey KR, Pavlova MN, Rohde AD, Hohmann JG, Crawley JN, (2007) Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze. Pharmacol Biochem Behav 86: 8-20.